Here, through a cross with a CD226-mutated mouse, Guillerey et al. showed the pivotal role of CD226 expression in the early phases of MM development [39], since CD226 downregulation promoted immune-evasion from NK and T cell surveillance and disease progression [39]. The gene discussed is CD226; the disease is Miyoshi myopathy.